Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.5K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.5K
Multiple Allele Traits01:49

Multiple Allele Traits

37.8K
The Concept of Multiple Allelism
37.8K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASD Diameter Indexed to Total Septal Length Outperforms Expert Opinion in Predicting Future Candidacy for Percutaneous ASD Closure.

Pediatric cardiology·2026
Same author

Multi-trait and Gene-Based Analyses Identify Genetic Variants Associated with Spontaneous Coronary Artery Dissection.

medRxiv : the preprint server for health sciences·2026
Same author

On the provenance of spontaneous coronary artery dissection.

European heart journal open·2026
Same author

Using Atrial Cardiomyopathy Metrics to Characterize Atrial Fibrillation in Endurance Athletes.

JACC. Clinical electrophysiology·2026
Same author

Increased Risk of Disabilities in Children and Adolescents With Congenital Heart Disease of Any Severity.

Journal of the American Heart Association·2026
Same author

A three generation family with VACTERL association is found to have a rare form of diamond-blackfan anaemia.

European journal of human genetics : EJHG·2026

Related Experiment Video

Updated: Jan 3, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K

VPOT: A Customizable Variant Prioritization Ordering Tool for Annotated Variants.

Eddie Ip1, Gavin Chapman1, David Winlaw2

  • 1Victor Chang Cardiac Research Institute, Sydney 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney 2052, Australia.

Genomics, Proteomics & Bioinformatics
|November 26, 2019
PubMed
Summary
This summary is machine-generated.

VPOT is a new tool that helps researchers prioritize genetic variants from next-generation sequencing data. This variant prioritization ordering tool (VPOT) creates a custom pathogenicity score, improving disease-causal variant identification.

Keywords:
Customizable rankingGenomic annotationNext-generation sequencingPathogenicity predictionsVariant prioritization

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.1K
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.7K

Related Experiment Videos

Last Updated: Jan 3, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.1K
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.7K

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Next-generation sequencing (NGS) generates numerous genetic variants per sample.
  • Identifying disease-causing variants requires extensive filtering and pathogenicity score analysis.
  • Current methods are labor-intensive and can be inefficient for large datasets.

Purpose of the Study:

  • To develop a flexible and efficient tool for prioritizing genetic variants.
  • To enable researchers to create customizable pathogenicity scores for variant analysis.
  • To improve the identification of disease-causal variants from NGS data.

Main Methods:

  • Developed VPOT (Variant Prioritization Ordering Tool), a Python-based command-line tool.
  • VPOT allows customizable weighting of various annotation metrics and pathogenicity scores.
  • Implemented additional filtering functions based on gene lists and family pedigrees.

Main Results:

  • VPOT generates a single, fully customizable pathogenicity ranking score.
  • The tool facilitates cohort analysis by prioritizing variants within a group.
  • VPOT demonstrated superior efficacy, flexibility, scalability, and computational performance compared to similar tools.

Conclusions:

  • VPOT offers a powerful and adaptable solution for genetic variant prioritization.
  • The tool streamlines the identification of potential disease-causal variants.
  • VPOT is freely available, promoting wider adoption in genetic research.